COMPPARE advances evidence shaping prostate cancer care
Nearly ten years after the launch of the COMPPARE study, its insights are helping to define the future of prostate cancer treatment.
Nearly ten years after the launch of the COMPPARE study, its insights are helping to define the future of prostate cancer treatment.
The goal of the statewide program is to support innovative cancer research and treatment models.
Researchers analyzed plasma from 195 Black American men who later developed prostate cancer and 379 matched controls from the Southern Community Cohort Study.
This National Cancer Survivor Month, Bishop Stokes shared his story, encouraging others to make their health a priority.
A large national clinical trial funded by the Patient-Centered Outcomes Research Institute (PCORI) has shown outstanding early outcomes for prostate cancer patients treated with both proton therapy and standard photon radiation therapy. Nancy Mendenhall, M.D. Nancy Mendenhall, M.D., medical director of the UF Health Proton…
Researchers can now quickly screen chemicals using an online tool that flags high-risk chemicals.
The gathering at Springhill Church aimed to empower men to lead healthy, informed lives.
The pilot funding was awarded to researchers who conduct research in the center’s Mechanisms of Oncogenesis research program.
Noah Hammarlund, Ph.D., and team found that residential location-related factors explain only half of the treatment inequities experienced by Black patients.
The groups will offer prostate cancer screening via PSA testing and health education at the Florida-LSU football game.